SCHEMBL10421663

SCHEMBL10421663

Cc1cc(N/N=C(\C#N)C(=O)NC(=O)O)cc(Cl)c1C(C)(C#N)c1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
RAPGEF3 O95398 15/20 0.47
RAPGEF4 Q8WZA2 8/20 0.47
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
NPY1R P25929 1/20 0.40
HTT P42858 1/20 0.40
NPY2R P49146 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10421664 1.00 ALOX12 (0.48) ALOX12MEN1KMT2ARAPGEF3RAPGEF4
SCHEMBL10421616 0.95 ALOX12 (0.50) ALOX12MEN1KMT2ARAPGEF3RAPGEF4
SCHEMBL10421615 0.95 ALOX12 (0.50) ALOX12MEN1KMT2ARAPGEF3RAPGEF4
SCHEMBL10420084 0.85 RAPGEF3 (0.52) ALOX12MEN1KMT2ARAPGEF3RAPGEF4
SCHEMBL10420082 0.85 RAPGEF3 (0.52) ALOX12MEN1KMT2ARAPGEF3RAPGEF4
SCHEMBL10675097 0.84 RAPGEF3 (0.43) ALOX12MEN1KMT2ARAPGEF3RAPGEF4
SCHEMBL10675101 0.84 RAPGEF3 (0.43) ALOX12MEN1KMT2ARAPGEF3RAPGEF4
SCHEMBL5563751 0.82 RAPGEF3 (0.54) ALOX12MEN1KMT2ARAPGEF3RAPGEF4
SCHEMBL5563754 0.82 RAPGEF3 (0.54) ALOX12MEN1KMT2ARAPGEF3RAPGEF4
SCHEMBL10420125 0.81 MEN1 (0.43) ALOX12MEN1KMT2ARAPGEF3RAPGEF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0170316-B1 ALPHA-ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN-2(3H)-YL)BENZENEACETONITRILES JANSSEN PHARMACEUTICA N.V. (BE) 1990-05-30 EP disclosed
EP-0170316-A2 alpha-Aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)benzeneacetonitriles JANSSEN PHARMACEUTICA N.V. (BE) 1986-02-05 EP disclosed